Skip to main content
      Rheumatologist - pharmacist co-management of MTX initiators @GeisingerHealth Philadelphia

      Having the dual skill set act

      David Liew drdavidliew

      1 year ago
      Rheumatologist - pharmacist co-management of MTX initiators @GeisingerHealth Philadelphia Having the dual skill set actually helped with adherence to guidelines vs standard care. Would be great to see how this works with implementation in RA clinics #ACR23 ABST2484 @RheumNow https://t.co/88R1BYzYn5
      #ACR23 Abstr# 2490 Data supporting aggressive early treatment in #SLE? Multicentre open label RCT in China showed low do

      Md Yuzaiful Md Yusof

      1 year ago
      #ACR23 Abstr# 2490 Data supporting aggressive early treatment in #SLE? Multicentre open label RCT in China showed low dose MMF + Pred 0.5mg/kg/d reduced severe flare & lupus nephritis cases vs HCQ + Pred in new onset SLE with high dsDNA but w/o major organ involvement @RheumNow https://t.co/oRlgCaOvXo
      Watch: Utility of AI and ChatGPT in Rheumatology

      Dr. Kathryn Dao interviews Dr. Richard Stern at the 2023 ACR Converge

      Dr. John Cush RheumNow

      1 year ago
      Watch: Utility of AI and ChatGPT in Rheumatology Dr. Kathryn Dao interviews Dr. Richard Stern at the 2023 ACR Convergence meeting in San Diego, CA. #ACR23 https://t.co/SH0TGAdvm8 https://t.co/RHu8bH9YOG
      TM86 #ACR23 @RheumNow
      Auricular chondritis, arthritis, axonopathy, high inflamm. Initial Dx: RP
      Exam: lymphadenopathy,

      Eric Dein

      1 year ago
      TM86 #ACR23 @RheumNow Auricular chondritis, arthritis, axonopathy, high inflamm. Initial Dx: RP Exam: lymphadenopathy, erythema nodosum, TJC 36, SJC 4 (knees/ankles), decr sensation, asymm reflex, macular rash, nerve thicken Skin bx: septal panniculitis wo vasc Dx: leprosy https://t.co/P5QJArRDaA
      #Cardiovascular imaging will help to detect #cardiac abnormalities earlier@in #rheumatic #diseases. #ACR23 ⁦@RheumNow?

      Janet Pope

      1 year ago
      #Cardiovascular imaging will help to detect #cardiac abnormalities earlier@in #rheumatic #diseases. #ACR23 ⁦@RheumNow⁩ ⁦@ACRheum⁩ 14T118 https://t.co/QKCpLWtkUv
      🚩Adjunct therapy to treat vasculopathy of MDA5-DM
      ⭐️Botox heals digital ulcerations and improves Raynaud's (slide

      Meral K. El Ramahi, MD MeralElRamahiMD

      1 year ago
      🚩Adjunct therapy to treat vasculopathy of MDA5-DM ⭐️Botox heals digital ulcerations and improves Raynaud's (slide 1) Dr. Katherine Shaw injects Botox for healing recalcitrant ulcerated Gottron's papules (example patient failed nifedipine, sildenafil, pentoxyfylline & while on… https://t.co/4XCvRrzeTL https://t.co/yxUCzS30W1
      What do we know about IL1 drugs in #OA only a small few stidies prior to CANTOS .
      COLCHCINE didnt seem to work

      LoDoCO2

      Bella Mehta bella_mehta

      1 year ago
      What do we know about IL1 drugs in #OA only a small few stidies prior to CANTOS . COLCHCINE didnt seem to work LoDoCO2 post hoc analysis may work? @RheumNow #ACR23 https://t.co/h4oVRppI5S
      Gene signature predicts RA trajectory during pregnancy:

      Blood RNAseq *before* pregnancy

      🚺 improve during preg: Str

      Aurelie Najm

      1 year ago
      Gene signature predicts RA trajectory during pregnancy: Blood RNAseq *before* pregnancy 🚺 improve during preg: Strong Neutrophil signature 🚺 experience dis worsening: Strong B cell signature Needs replication but could have major implications! @RheumNow #ACR23 ABST2481 https://t.co/gOHwEvOOM6
      #ACR23 Abstr# 2487 How to reduce PBO response in #SLE trials? Try adding low dose GC as co-primary endpoint. Interim ana

      Md Yuzaiful Md Yusof

      1 year ago
      #ACR23 Abstr# 2487 How to reduce PBO response in #SLE trials? Try adding low dose GC as co-primary endpoint. Interim analysis of Phase 2 RCT: SRI-4 + sustained GC dose to ≤5mg/d or ≤BL from Wk16 to 28 was met more in Ianalumab (BAFF-R-i) vs PBO (44% vs 9%) @RheumNow https://t.co/JEnMWKilR6
      TM85 #ACR23 @RheumNow
      IPF s/p lung transplant p/w diffuse bone pain
      Exam: no synovitis, +crackles. Labs: ALP 203
      CT che

      Eric Dein

      1 year ago
      TM85 #ACR23 @RheumNow IPF s/p lung transplant p/w diffuse bone pain Exam: no synovitis, +crackles. Labs: ALP 203 CT chest: stable mycetoma Xray: periosteal reaction Dx: vericonazole periosititis Positive Mucorales PCR, fluoride level 19 (ref <4) Bone pain improved stopping voric https://t.co/Gt8mOAssvh
      Anti-fibrotics in RA-ILD
      Retro analysis of 74 pts

      AEs frequent 55% and discontinuation in 46% (more than in initial RC

      Aurelie Najm

      1 year ago
      Anti-fibrotics in RA-ILD Retro analysis of 74 pts AEs frequent 55% and discontinuation in 46% (more than in initial RCTs) No diff between AF FCV trajectory mildly improved ABST2479 @RheumNow @Juge_P_A @PhilippeDieude #ACR23 https://t.co/GqsHxkIFgD
      Rashes in Rheumatology at #ACR23

      Which disease entity are these palms pathognomonic for?

      @RheumNow https://t.co/NmT1LT

      Meral K. El Ramahi, MD MeralElRamahiMD

      1 year ago
      Rashes in Rheumatology at #ACR23 Which disease entity are these palms pathognomonic for? @RheumNow https://t.co/NmT1LTzWmm
      Therapeutic Ladder for Discoid Lupus:

      1. Strict🌞protection, smoking avoidance
      2. Antimalarials
      3. Topicals/intrales

      Meral K. El Ramahi, MD MeralElRamahiMD

      1 year ago
      Therapeutic Ladder for Discoid Lupus: 1. Strict🌞protection, smoking avoidance 2. Antimalarials 3. Topicals/intralesional corticosteroids, topical CNI 4. Oral steroids, retinoids, MTX, MMF 5. Thalidomide, lenalidomide 6. IVIG, JAKi, Belimumab... BUT also Anifrolumab!… https://t.co/xSw0s12Uvk https://t.co/stIJ944d9A
      #ACR23 Abstr# 2485 Belimumab therapy in RCT was associated with increased risk of psychiatric events inc suicidality vs

      Md Yuzaiful Md Yusof

      1 year ago
      #ACR23 Abstr# 2485 Belimumab therapy in RCT was associated with increased risk of psychiatric events inc suicidality vs PBO. When compared with standard immunosuppressant, real-world data using emulated trial design showed no increased risk @RheumNow https://t.co/Vqhc5yRsSA